Skip to main content
. 2018 Jul 23;3(5):e000398. doi: 10.1136/esmoopen-2018-000398

Figure 5.

Figure 5

Euler-Venn diagram showing concordance of MTB decision with OncoKB recommendations for molecular driven targeted therapy; comparison of (A) MTB and ttNGS cohort, (B) MTB and lbNGS cohort and (C) matched MTB, lbNGS and ttNGS. lbNGS, liquid biopsy NGS; MTB, molecular tumour board; NGS, next generation sequencing; ttNGS, tumour tissue NGS.